Join Dr. Aliya Khan, Clinical Professor of Medicine, Division of Endocrinology and Geriatrics, Director of the Calcium Disorders Clinic, and Director of the Fellowship in Metabolic Bone Disease at McMaster University, and Dr. Famida Jiwa, President and CEO, Osteoporosis Canada for a practical discussion of new Canadian real-world evidence on the patient experience of switching from reference denosumab to biosimilar denosumab. The speakers will explore what the research tells us about patient satisfaction, communication, treatment confidence, affordability and access, and what these findings mean in everyday clinical practice.
